MicroRNA‐302c‐3p inhibits endothelial cell pyroptosis via directly targeting NOD‐, LRR‐ and pyrin domain‐containing protein 3 in atherosclerosis
出版年份 2021 全文链接
标题
MicroRNA‐302c‐3p inhibits endothelial cell pyroptosis via directly targeting NOD‐, LRR‐ and pyrin domain‐containing protein 3 in atherosclerosis
作者
关键词
-
出版物
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 25, Issue 9, Pages 4373-4386
出版商
Wiley
发表日期
2021-03-30
DOI
10.1111/jcmm.16500
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- tsRNAs: Novel small molecules from cell function and regulatory mechanism to therapeutic targets
- (2021) Tingyu Zong et al. CELL PROLIFERATION
- Long noncoding RNA XXYLT1-AS2 regulates proliferation and adhesion by targeting the RNA binding protein FUS in HUVEC
- (2020) Qi Wang et al. ATHEROSCLEROSIS
- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- Insights into the regulatory role of circRNA in angiogenesis and clinical implications
- (2020) Yan Liu et al. ATHEROSCLEROSIS
- The kinase inhibitor BX795 suppresses the inflammatory response via multiple kinases
- (2020) Tao Yu et al. BIOCHEMICAL PHARMACOLOGY
- Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators
- (2020) Dongling Liu et al. BIOCHEMICAL PHARMACOLOGY
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- The biomarkers of key miRNAs and target genes associated with acute myocardial infarction
- (2020) Qi Wang et al. PeerJ
- Epigenetic Mechanisms of Inflammasome Regulation
- (2020) Giulia Poli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
- (2020) Max J. M. Silvis et al. Journal of Cardiovascular Translational Research
- Functional roles and mechanisms of ginsenosides from Panax ginseng in atherosclerosis
- (2020) Qianqian Xue et al. Journal of Ginseng Research
- Piwi-interacting RNAs (piRNAs) as potential biomarkers and therapeutic targets for cardiovascular diseases
- (2020) Min Li et al. ANGIOGENESIS
- Non‐coding RNAs in aortic dissection: From biomarkers to therapeutic targets
- (2020) Mengdie Cheng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- NLRP3 inflammasome in endothelial dysfunction
- (2020) Baochen Bai et al. Cell Death & Disease
- Long Non-coding RNA PEBP1P2 Suppresses Proliferative VSMCs Phenotypic Switching and Proliferation in Atherosclerosis
- (2020) Xingqiang He et al. Molecular Therapy-Nucleic Acids
- MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1
- (2019) Shaoyan Liu et al. Frontiers in Genetics
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
- (2019) Magnus Bäck et al. Nature Reviews Cardiology
- Protective effects of microRNA‐22‐3p against retinal pigment epithelial inflammatory damage by targeting NLRP3 inflammasome
- (2019) Zizhong Hu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases
- (2019) Nina Boxberger et al. JOURNAL OF IMMUNOLOGY
- Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation
- (2019) Tao Zhuang et al. CIRCULATION RESEARCH
- MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model
- (2019) Qiang Sun et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
- (2019) Patricia Marchio et al. Oxidative Medicine and Cellular Longevity
- A potential role of microvesicle-containing miR-223/142 in lung inflammation
- (2019) Duo Zhang et al. THORAX
- miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock
- (2019) Zhenyi Xue et al. Cell Death & Disease
- MicroRNA 223 3p Negatively Regulates the NLRP3 Inflammasome in Acute and Chronic Liver Injury
- (2019) Carolina Jimenez Calvente et al. MOLECULAR THERAPY
- Atherothrombosis and the NLRP3 inflammasome – endogenous mechanisms of inhibition
- (2019) Mohan Satish et al. Translational Research
- Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
- (2019) Marcelo A. Mori et al. Cell Metabolism
- NLRP3 Inflammasome Activation by MicroRNA-495 Promoter Methylation May Contribute to the Progression of Acute Lung Injury
- (2019) Youguo Ying et al. Molecular Therapy-Nucleic Acids
- Understanding the role of non-coding RNA (ncRNA) in stent restenosis
- (2018) Shaoyan Liu et al. ATHEROSCLEROSIS
- MiR-302e attenuates allergic inflammation in vitro model by targeting RelA
- (2018) Lifeng Xiao et al. BIOSCIENCE REPORTS
- Noncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitus
- (2018) Ningning Tang et al. Cardiovascular Therapeutics
- NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
- (2018) Alena Grebe et al. CIRCULATION RESEARCH
- RNA Therapeutics in Cardiovascular Disease
- (2018) Tina Lucas et al. CIRCULATION RESEARCH
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis
- (2018) Binod Aryal et al. VASCULAR PHARMACOLOGY
- MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy
- (2018) Mohammad Mohajeri et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Role of pyroptosis in cardiovascular disease
- (2018) Zeng Zhaolin et al. CELL PROLIFERATION
- Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
- (2017) Wolfgang Poller et al. EUROPEAN HEART JOURNAL
- miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204
- (2017) Yanyan Yang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
- (2017) Zahra Hoseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis
- (2017) Yong Zhang et al. JOURNAL OF PINEAL RESEARCH
- Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
- (2017) Renqing Wang et al. LABORATORY INVESTIGATION
- The immunology of atherosclerosis
- (2017) Anton Gisterå et al. Nature Reviews Nephrology
- MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis
- (2017) S Li et al. ONCOGENE
- MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
- (2017) Dongsheng Li et al. Human Cell
- Targeting vascular (endothelial) dysfunction
- (2016) Andreas Daiber et al. BRITISH JOURNAL OF PHARMACOLOGY
- MicroRNA Regulation of Atherosclerosis
- (2016) Mark W. Feinberg et al. CIRCULATION RESEARCH
- Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
- (2016) Michael A. Gimbrone et al. CIRCULATION RESEARCH
- Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation
- (2016) S. Robertson et al. CLINICAL SCIENCE
- MicroRNAs in Cardiovascular Disease
- (2016) Temo Barwari et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
- (2016) Geena Paramel Varghese et al. Journal of the American Heart Association
- Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE–/– Mice
- (2015) Azadeh Kheirolomoom et al. ACS Nano
- MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation
- (2015) S. Chen et al. BLOOD
- Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
- (2015) Altaf Afrasyab et al. HEART AND VESSELS
- The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
- (2015) Yun-Hee Youm et al. NATURE MEDICINE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice
- (2015) Ying Tian et al. Science Translational Medicine
- MicroRNAs and their isomiRs function cooperatively to target common biological pathways
- (2011) Nicole Cloonan et al. GENOME BIOLOGY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started